Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04537403 · ClinicalTrials.gov registry record · Phase 1
PET Detection of CCR2 in Human Atherosclerosis
A Phase 1 study of Carotid Atherosclerosis, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04537403: Recruiting Phase 1 study of Carotid Atherosclerosis, sponsored by Washington University School of Medicine.
NCT04537403 is a Phase 1 study of Carotid Atherosclerosis that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 100 participants, below the 153-participant average among 5 other Carotid Atherosclerosis trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04537403, a Phase 1 study of Carotid Atherosclerosis, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
Primary Outcome
Injecting normal volunteers and patients who have blocked arteries with a single bolus injection. The dose of the injection is 8-10, and the above drug is measured in millicuries, which is a unit of radioactivity. the dose of millicuries will be 8-10 millicures
Conditions Studied
Interventions
- DRUG Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
- DRUG Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)
Study Locations (1)
Missouri
- Washington University CCIR - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2025-09-01 |
| Phase | Phase 1 |
What NCT04537403 shows while recruiting
NCT04537403 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 153-participant average among 5 other Carotid Atherosclerosis trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Carotid Atherosclerosis appearing as the primary indexed condition, and to 2 interventions - of which Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine) is the first listed.
NCT04537403 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04537403 about?
NCT04537403 is a clinical study titled "PET Detection of CCR2 in Human Atherosclerosis". : Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
What is the current status of trial NCT04537403?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2020-10-01. Estimated completion is 2025-09-01.
What conditions does trial NCT04537403 study?
This clinical trial studies the following conditions: Carotid Atherosclerosis.
What interventions are being tested in trial NCT04537403?
The interventions under investigation include: Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine) (DRUG), Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine) (DRUG).
Who is sponsoring clinical trial NCT04537403?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04537403 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Potential Risk Factors for Stroke
COMPLETED · Phase 1
-
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis
COMPLETED · Phase 1
-
CANF-Comb-II PET-MR in Atherosclerosis Multisite
RECRUITING
-
Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound
ACTIVE NOT RECRUITING · Phase 4
-
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI